RGNX
Regenxbio
$9.71
−$0.02 (−0.21%)Jul 27, 2026
Key metrics
The numbers that frame RGNX today
- Market cap
- $501.98M
- P/E (TTM)
- -1.7
- EV / FCF
- -3.1
- Gross margin
- 68.2%
- EV / Sales
- 8.3
- ROIC
- -42.2%
- Div yield
- 0%
- Debt / equity
- 11.8
- 52wk Low
- $5.46
- 52wk High
- $16.19
Growth
Revenue and earnings trend for RGNX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RGNX
Is Regenxbio a good buy?
No. Regenxbio has weak quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Regenxbio is selling at a very high price.
What is the market capitalization of RGNX?
Regenxbio's market capitalization is $501.98M.
What is the P/E ratio for RGNX stock?
Regenxbio's current P/E ratio is -1.7.
What is the 52-week high for RGNX stock?
The 52-week high for Regenxbio is $16.19. The current close of $9.71 is 40% below that high.
What is the 52-week low for RGNX stock?
The 52-week low for Regenxbio is $5.46. The current close of $9.71 is 77.8% above that low.
Does RGNX stock pay dividends?
Regenxbio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RGNX?
Regenxbio's Debt / Equity ratio is 11.78.